drugset / Trial / NCT02208973

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses"

NCT02208973 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

To assess the safety and tolerability of five doses of PBF-680 (5 mg, 10 mg, 20 mg, 40 mg and 60mg) after repeated (8 days) single daily oral dose administration in young male and female healthy subjects.

Timeline

Start
2014-05
Primary completion
2014-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PBF-680 Unknown 5 mg Oral
Subject PBF-680 Unknown 10 mg Oral
Subject PBF-680 Unknown 20 mg Oral
Subject PBF-680 Unknown 40 mg Oral
Subject PBF-680 Unknown 60 mg Oral

Indications